Weijing Sun, MD, FACP, discusses the design of the KEYNOTE-062 trial in advanced gastric/gastroesophageal junction cancer.
Weijing Sun, MD
Advertisement
Articles by Weijing Sun, MD
Weijing Sun, MD, FACP, discusses the use of ramucirumab plus paclitaxel in metastatic gastric cancer.
Weijing Sun, MD, FACP, discusses remaining challenges in the first-line treatment of patients with gastric cancer.
Weijing Sun, MD, gastrointestinal oncologist at the University of Kansas School of Medicine, discusses the debate between the use of radiation and chemotherapy in patients with locally advanced gastroesophageal junction (GEJ) adenocarcinoma.
Advertisement
Latest Updated Articles
Dr. Sun Discusses the Debate Between Radiation and Chemotherapy in GEJ CancersPublished: January 15th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
4
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
5